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Purpose: To illustrate the profile of the cases of intoxications by antiepileptic drugs
(AEDs) registered within a large urban area during the period of 1 year.
Methods: A cross-sectional observational study was performed in the Intoxication
Control Center of the Sa˜o Paulo City Hospital. We evaluated 6535 medical consults of
intoxication cases involving prescription and over-the-counter drugs in 2001. We
selected and analyzed the cases involving AEDs. Statistical analysis was performed in
order to evaluate the frequency of different drug types and the circumstance of drug
exposure.
Results: The most frequently observed AEDs were phenobarbital, carbamazepine,
diazepam, and clonazepam. The frequency of intoxication cases among different age
groups did not significantly differ according to the drug type. The circumstances
involving AEDs intoxication were analogous to the circumstances of the cases of
intoxication involving all other medications (p > 0.05).
Conclusions: There are a large number of intoxications involving AEDs. Imposing a
restriction access to AEDs can be deleterious to patients that depend on AEDs,
however, a strict program of AEDs distribution should be considered to reduce the
cases of AED intoxication.
# 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.3788 7292;
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05 BEA Trading Ltd. PublishedIntroductionEpilepsy is a frequent and serious disorder,1 affect-
ing approximately 1% of the world population.2—4 In
Brazil, a recent study has shown a cumulated pre-
valence of epilepsy of 18.6/1000 habitants,5 whereby Elsevier Ltd. All rights reserved.
Antiepileptic drugs: a study by Sa˜o Paulo Intoxication Control Center 171it is estimated that over 3 million people have some
form of epilepsy. Non-recurrent seizures are also
very common and up to 5% of the population is
expected to have a seizure during lifetime.6
The current mainstay for epilepsy treatment is
the use of antiepileptic drugs (AEDs). The majority
of newly diagnosed children and adults with epilepsy
can be successfully treated with AEDs1 and may
become seizure-free after the pharmacological
treatment.7
Since epilepsy and non-recurrent seizures are
highly prevalent, AED prescriptions are also common
place among the general population. The continu-
ous nature of the epilepsy treatment and the daily
use of medication also contributes to the readily
accessibility to AEDs.8
AEDs comprise approximately 3% of intoxication
cases in the US.9 This number is yet largely unknown
in developing countries. Since AEDs are usually
central nervous system (CNS) depressants, intoxica-
tions involving AEDs can lead to the occurrence of
potentially dangerous clinical presentation and high
risk of fatal consequences. The understanding of the
frequency of the involvement of AEDs in intoxication
may help prevent potentially adverse outcomes.
The present study aims to illustrate the profile of
the cases of intoxication by AEDs in a urban area of
Brazil. We present the cases of intoxication by AEDs
registered by the Intoxication Control Center of Sa˜o
Paulo (ICCSP) within the period of 1 year.Methods
Place of the study
The ICCSP is an agency devoted to provide technical
support for medical emergencies due to intoxica-
tion. It primarily works by attending telephone
requests frommedical facilities from the urban area
and outskirts of the City of Sa˜o Paulo, Southeastern
Brazil. It offers specialized non-stop medical sup-
port performed by a trained team of physicians.
These professionals also provide health care to
patients victims of intoxication at the Sa˜o Paulo
City Hospital Dr. Artur Ribeiro de Saboya, where it
is located. The treatment follow-up is performed in
the Sa˜o Paulo City Hospital, if the patient is based in
this hospital. If the treatment is being oriented by
phone, once the first telephone contact is made, the
treatment follow-up and case ascertainment is per-
formed by daily contact between the ICCSP and the
center where the patient is based and being trea-
ted. In addition, the ICCSP offers medical and basic
information related to intoxication risks and primary
care to the general population.Patients and methods
We performed a cross-sectional observational study.
The ICCSP performed 6535 medical consults of
intoxication cases involving prescription and over-
the-counter drugs in 2001. All records were
reviewed and those containing information of intox-
ication due to products containing CNS-acting drugs
were selected. During the period comprised
between January 1st, 2001 and December 31st,
2001, 2325 intoxication cases involving CNS-acting
drugs were found. Among these cases, 1280 cases
mentioned AEDs including all benzodiazepines
(BZDs). The cases involving the BZDs used mainly
for anxiolytic and hypnotic purposes (alprazolam,
bromazepam, chlorazepate, chlordiazepoxide,
chlormezanona, cloxazolam, estazolam, flunitraze-
pam, flurazepam, and nitrazepam) were excluded
(N = 252); whereas all cases involving clobazam,
clonazepam, diazepam, lorazepam, and midazolam
were included (N = 472). After the inclusion and
exclusion criteria described above, we observed
1028 cases of intoxication due to AEDs in the year
of 2001.
Data analysis
The medical records were stored through the com-
puter program dBase IV. Graphic presentations of
results were built using Excel 2000 for Windows. The
data was described in numbers, and when appro-
priate, in percentage. Statistical analysis was per-
formed with Systat 9.0 for Windows. We used
Pearson’s x2 and Cohen k coefficient to evaluate
the association and its strength of the frequencies of
distribution of data among different drug groups.
Statistical significance was set at p < 0.05.Results
Almost 36% of all cases registered by ICCSP involved
CNS-acting drugs. AEDs comprised 16% of all drugs
and 44% of CNS-acting drugs (Table 1).
The most frequent AED involved in intoxication
cases was phenobarbital. The number of intoxica-
tions due to the use of phenobarbital comprised
10.75% of the intoxications with CNS acting drugs,
and 3.83% of all drug intoxications registered by the
ICCSP. The second most common AED to be involved
in intoxication cases was carbamazepine, which was
observed in 9.42% of the cases of intoxication invol-
ving CNS drugs, and in 3.35% of all cases. Diazepam
and clonazepam were also frequent, comprising
each one 8.56% of the cases of CNS drugs intoxica-
tions, and 3.05% of all drug intoxication cases.
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Table 1 Absolute number and frequency of the cases of intoxication by CNS acting drugs, discriminated by drug type.
Drug Number
of cases
Percentage among
CNS acting drugs
Percentage among
all cases
Alprazolam 40 1.72 0.61
Bromazepam 131 5.63 2.00
Clobazam 9 0.39 0.14
Clonazepam 199 8.56 3.05
Chlorazepate 1 0.04 0.02
Chlordiazepoxide 23 0.99 0.35
Chlormezanona 3 0.13 0.05
Cloxazolam 24 1.03 0.37
Diazepam 199 8.56 3.05
Estazolam 3 0.13 0.05
Flunitrazepam 15 0.65 0.23
Flurazepam 7 0.3 0.11
Lorazepam 39 1.68 0.60
Midazolam 26 1.12 0.40
Nitrazepam 5 0.22 0.08
Carbamazepine 219 9.42 3.35
Phenobarbital 250 10.75 3.83
Valproic acid 26 1.12 0.40
Cloral hydrate 3 0.13 0.05
Phenytoin 51 2.19 0.78
Gabapentine 2 0.09 0.03
Oxcarbazepine 3 0.13 0.05
Topiramate 2 0.09 0.03
Total of AEDs 1028 44 15.73
Total of CNS acting drugs 2325 100 35.58
Total of drugs 6535 100.00
AEDs are showed in bold.Among AEDs, phenobarbital, carbamazepine,
diazepam, clonazepam, and phenytoin were the
most frequent drugs and altogether were responsi-
ble for 89.4% of the intoxications due to AEDs
(Table 1).
The distribution of the frequency of AEDs intox-
ication cases among age ranges is shown in Fig. 1.WeFigure 1 Frequency of the cases of intoxicatiobserved two age-ranges when intoxication was
more frequent: one between 1 and 4 years and
the other between 25 and 29 years. These two peaks
were consistently found in the same age ranges
when different classes of drugs were analyzed. They
were also observed in the analysis of the distribution
of frequency of intoxication in different age rangeson distributed among different age groups.
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Figure 2 Distribution of the frequency of the circumstance of the intoxication grouped for different drug types.for all classes of drugs grouped altogether. The
frequency of intoxication cases among different
age groups did not differ significantly according to
drug type Pearson’s x2 = 30, p = 0.224, Cohen
k = 0.2.
The circumstances involving AEDs intoxication
were analogous to the circumstances of the cases
of intoxication involving all other medications
(Fig. 2). Suicide attempt was the most frequent
circumstance observed, followed by accidents and
erroneous therapeutic use. The frequency of cases
among different circumstances did not differ sig-
nificantly according to drug type Pearson’s x2 = 16,
Cohen k = 0.25, p = 0.22.Discussion
Intoxication involving AEDs is probably an under-
estimated cause of medical attention in Brazil.
According to our data, approximately 44% of all
intoxications due to CNS-acting drugs may involve
AEDs. In a large urban area, with approximately 10
million inhabitants, more than a thousand cases
occur each year. This means that at least three
cases involving AEDs occur everyday day and raises
an estimated incidence of 1 case/10,000 inhabi-
tants/year.
In the present study, we have aimed to evaluate
the frequency of cases where the intake of AEDs
generated health hazard and yielded a consult to an
intoxication control center, either in a person of
epilepsy or not. We have not evaluated the back-
ground of drug exposure and the outcome regarding
the intoxication involving AEDs, which may vary
largely regarding the type of drug and the dosage.
We, therefore, did not aim to evaluate whether the
cases of intoxication involving AEDs differed inpatients with epilepsy compared to the remaining
population. Conversely, we aimed to provide a
cross-sectional scenario of the frequency of AEDs
within cases of drug intoxication that lead to med-
ical attention.
The reasons that make AEDs notifications to a
Poison Control Center so common can be ascribed to
some epidemiological issues involving the treatment
of epilepsy. First, AEDs are largely known as ‘‘strong
brain medications’’ and this may account for the
peak of cases observed in young adults, typically
during suicide attempts. This can be especially
important in patients with epilepsy, in whom co-
existing depression is frequent, and usually over-
looked. Second, patients with epilepsy sometimes
store medication in their houses because the large
amount of medication taken daily and because the
long term features of the treatment. The readily
availability of AEDs increases the likelihood that it
may be involved in a toxic event. Third, children
that live together or nearby individuals with epi-
lepsy may be particularly prone to accidental expo-
sures to AEDs because the large amount of
medication is sometimes within full range of access.
This may account for the peak of incidence of
intoxications in the pediatric population. Finally,
patients accustomed to consuming large amounts
of AEDs may also be susceptible to intoxications by a
casual mistake during the intake of medication, and
this may explain the frequency of cases in all age
ranges.
In this study, we have not aimed to compare the
intoxication cases involving AEDs to intoxication
cases involving other drugs. Conversely, we have
aimed to investigate the burden of AEDs in cases of
intoxication by evaluating the frequency that AEDs
are involved in cases that motivated a consult
to an intoxication center. Probably, this is an
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generate a consult, but these numbers are an
accurate reflection of the overall scenario of
intoxications within an urban area.
Phenobarbital and carbamazepine are the most
common AEDs involved in intoxication cases. This
may be a reflection of the fact that these two
medications are commonly prescribed to patients
with epilepsy in Brazil. Unfortunately, the fre-
quency of prescription of different AEDs is unknown,
as is unknown how frequent AEDs are prescribed to
other medical conditions such as mood disorder and
pain control. However, other commonly prescribed
AEDs drugs such as phenytoin do not rank as the first
AEDs involved in intoxication. Therefore, the fre-
quency that an AED is associated to intoxication is
probably not correlated with the frequency of pre-
scription. This calls attention to those drugs with
potentially deleterious effects. Phenobarbital is the
leading cause of intoxication involving AEDs and its
lethal dose may vary from several factors, but an
oral dose of 1 g can generate poisoning in an adult
and as little as 6 g can be fatal, particularly when it
is taken with alcohol.10
Some strategies may offer help to prevent the
large number of medical cases by AEDs. Depression
has a high incidence in patients with epilepsy and is
one of the major contributors to the impairment in
the quality of life observed in these patients.11 It is
possibly overlooked and it may contribute to the
elevated number of cases of intoxication involving
AEDs. If this problem is directly addressed, and if
health care resources are oriented to combat
depression co-morbidity in patients with epilepsy,
the frequency of suicide attempt with AEDs can
substantially decrease.
The access to information about the AEDs and
access to the medication itself can also modulate
the frequency of AEDs intoxication cases. The cur-
rent policy for the medication distribution and the
lack of proper education concerning safe usagemay
be responsible for an overt access to AEDs and
consequently to toxic events. In the other hand,
the restricted access to AEDs can be deleterious to
patients that depend on AEDs. Thus, a carefully
designed program of information concerning AEDs
and an organized, controlled program of AEDs dis-
tribution is a strategy to avoid unnecessary storage
of medication by people in the community, and
therefore, lower the risk of intoxication.12 A pro-
gram of AEDs distribution could also help to offer
the medication to the patients according to their
needs and prevent the erratic availability of AEDs inpublic health facilities due to uneven distribu-
tion.12,13 Moreover, the program of AEDs distribu-
tion should be specifically focused on drugs that are
more common and also responsible for the larger
number of intoxications. According to the data we
presented, special attention should be devoted to
phenobarbital.
The definition of the real needs for the use of
AEDs is the first step to the planning of the proper
distribution of AEDs. Epidemiological studies
devised to map the size of the needs for AEDs based
on the frequency and distribution of people with
epilepsy are probably the best approach. Many
issues concerning the epidemiology of intoxication
due to AEDs remain to be clarified. The definition of
the epidemiological profile of the intoxication cases
involving AEDs is probably the first step to guide
further goal-oriented actions in the prevention of
the potentially serious consequences of the misuse
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